Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review

被引:38
作者
Li, Dennis H. [1 ,2 ,3 ]
Benbow, Nanette [1 ,3 ]
Keiser, Brennan [2 ]
Mongrella, Melissa [2 ]
Ortiz, Kasim [2 ]
Villamar, Juan [1 ,3 ]
Gallo, Carlos [1 ,3 ]
Deskins, Jasmine S. [2 ]
Hall, Casey D. Xavier [2 ,4 ]
Miller, Corinne [5 ]
Mustanski, Brian [1 ,2 ,3 ,4 ]
Smith, Justin D. [6 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, 625 N Michigan Ave,Suite 1400, Chicago, IL 60657 USA
[2] Northwestern Univ, Inst Sexual & Gender Minor Hlth & Wellbeing, Chicago, IL 60657 USA
[3] Northwestern Univ, Feinberg Sch Med, Ctr Prevent Implementat Methodol, Chicago, IL 60657 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60657 USA
[5] Northwestern Univ, Feinberg Sch Med, Gaiter Hlth Sci Lib, Chicago, IL 60657 USA
[6] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT USA
关键词
HIV; AIDS; pre-exposure prophylaxis; determinants of implementation; systematic review; implementation science; consolidated framework for implementation research; UNITED-STATES; HEALTH; PREP; CARE; INTERVENTIONS; PREVENTION; MEN; SEX; POPULATIONS; ADOLESCENTS;
D O I
10.1097/QAI.0000000000002984
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Delivery and use of HIV pre-exposure prophylaxis (PrEP) are suboptimal in the United States. Previous reviews of barriers and facilitators have not used an implementation science lens, limiting comprehensiveness and the link to implementation strategies. To summarize the state of the science, we systematically reviewed determinants of PrEP implementation using the updated Consolidated Framework for Implementation Research (CFIR 2.0). Setting: PrEP-eligible communities and delivery settings in the United States. Methods: In January 2021, we searched Ovid MEDLINE, PsycINFO, and Web of Science for peer-reviewed articles related to HIV/AIDS, interventions, implementation, and determinants or strategies. We identified 286 primary research articles published after 1999 about US-based PrEP implementation. Team members extracted discrete "mentioned" and "measured" determinants, coding each by setting, population, valence, measurement, and CFIR 2.0 construct. Results: We identified 1776 mentioned and 1952 measured determinants from 254 to 239 articles, respectively. Two-thirds of measured determinants were of PrEP use by patients as opposed to delivery by providers. Articles contained few determinants in the inner setting or process domains (ie, related to the delivery context), even among studies of specific settings. Determinants across priority populations also focused on individual patients and providers rather than structural or logistical factors. Conclusion: Our findings suggest substantial knowledge in the literature about general patient-level barriers to PrEP use and thus limited need for additional universal studies. Instead, future research should prioritize identifying determinants, especially facilitators, unique to understudied populations and focus on structural and logistical features within current and promising settings (eg, pharmacies) that support integration of PrEP into clinical practice.
引用
收藏
页码:S235 / S246
页数:12
相关论文
共 45 条
  • [1] "Scaling-out" evidence-based interventions to new populations or new health care delivery systems
    Aarons, Gregory A.
    Sklar, Marisa
    Mustanski, Brian
    Benbow, Nanette
    Brown, C. Hendricks
    [J]. IMPLEMENTATION SCIENCE, 2017, 12
  • [2] [Anonymous], 2018, COV SYST REV SOFTW
  • [3] [Anonymous], 2013, Antibiotic resistance threats in the United States
  • [4] [Anonymous], 2014, HIV Surveillance Report, 2014, V26
  • [5] A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective
    Bailey, Jennifer L.
    Molino, Suzanne T.
    Vega, Ana D.
    Badowski, Melissa
    [J]. INFECTIOUS DISEASES AND THERAPY, 2017, 6 (03) : 363 - 382
  • [6] Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs
    Bazzi, Angela R.
    Biancarelli, Dea L.
    Childs, Ellen
    Drainoni, Mari-Lynn
    Edeza, Alberto
    Salhaney, Peter
    Mimiaga, Matthew J.
    Biello, Katie B.
    [J]. AIDS PATIENT CARE AND STDS, 2018, 32 (12) : 529 - 537
  • [7] Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions
    Bazzi, Angela R.
    Drainoni, Mari-Lynn
    Biancarelli, Dea L.
    Hartman, Joshua J.
    Mimiaga, Matthew J.
    Mayer, Kenneth H.
    Biello, Katie B.
    [J]. BMC PUBLIC HEALTH, 2019, 19 (1)
  • [8] Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review
    Bradley, Erin
    Forsberg, Kaitlin
    Betts, Joshua E.
    DeLuca, Julia B.
    Kamitami, Emiko
    Porter, Sarah E.
    Sipe, Theresa Ann
    Hoover, Karen W.
    [J]. JOURNAL OF WOMENS HEALTH, 2019, 28 (09) : 1272 - 1285
  • [9] Damschroder LJ, 2022, IMPLEMENT SCI, V17, DOI [10.1186/s13012-022-01245-0, 10.1186/s13012-021-01181-5]
  • [10] Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
    Damschroder, Laura J.
    Aron, David C.
    Keith, Rosalind E.
    Kirsh, Susan R.
    Alexander, Jeffery A.
    Lowery, Julie C.
    [J]. IMPLEMENTATION SCIENCE, 2009, 4